Defending Life, Benefiting the World

Shanghai Hanyu Medical Technology Co., Ltd. (Hanyu Medical) was established in late 2016 and is located in Minhang District, Shanghai.

With its mission of "Defending Life, Benefiting the World," the company primarily engages in the research, development, production, and commercialization of interventional devices for structural heart disease. It owns subsidiaries including Hongyu Medical, Singapore Hanyu, and Guangdong Hanyu.

In the field of interventional devices for structural heart disease, the company's innovative "ValveClamp® Mitral Valve Clip System" received official approval from the National Medical Products Administration in early September 2023, becoming the first domestically produced mitral regurgitation interventional device approved for marketing. As of 2025, the product has entered commercial sales in Indonesia, Thailand, Singapore, Vietnam, and Colombia.